Controlled release hydrocodone formulations
US-8951555-B1 · Feb 10, 2015 · US
US9060940B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9060940-B2 |
| Application number | US-201414210565-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 14, 2014 |
| Priority date | Oct 30, 2000 |
| Publication date | Jun 23, 2015 |
| Grant date | Jun 23, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A solid oral controlled-release dosage form of hydrocodone is disclosed, the dosage form comprising an analgesically effective amount of hydrocodone or a pharmaceutically acceptable salt thereof, and controlled release material.
Opening claim text (preview).
We claim: 1. A method of providing effective pain relief to a patient in need thereof comprising: obtaining a serum profile of an opioid in the patient, having a plasma level with a C 24 /C max ratio of about 0.55 to about 1.0, by administering orally on a once-a-day basis a controlled release formulation of the opioid to the patient, wherein the controlled release formulation releases an analgesically effective amount of the opioid at an effective rate to provide said serum pr…
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.